Clinical features and endothelin receptor antagonist in primary Sjogren's syndrome with pulmonary arterial hypertension

被引：6
|
作者：
Chen, C-H
Chen, H-A
Yang, K-Y
Yu, W-C
Liao, H-T
Huang, D-F
机构：
[1] Vet Gen Hosp, Dept Med, Div Allergy Immunol & Rheumatol, Taipei 112, Taiwan
[2] Vet Gen Hosp, Chest Dept, Taipei 112, Taiwan
[3] Vet Gen Hosp, Div Cardiol, Dept Med, Taipei 112, Taiwan
[4] Natl Yang Ming Med Univ, Taipei, Taiwan
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2006年 / 35卷 / 03期
关键词：
D O I：
10.1080/03009740600765032
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：245 / 247
页数：3
相关论文
共 50 条
  • [1] Pulmonary Arterial Hypertension in Patients with Primary Sjogren's Syndrome
    Kobak, Senol
    Kalkan, Sezai
    Kirilmaz, Bahadir
    Orman, Mehmet
    Ercan, Ertugurul
    AUTOIMMUNE DISEASES, 2014, 2014
  • [2] Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
    Annette S Droste
    David Rohde
    Mirko Voelkers
    Arthur Filusch
    Thomas Bruckner
    Mathias M Borst
    Hugo A Katus
    F Joachim Meyer
    Respiratory Research, 10
  • [3] Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
    Droste, Annette S.
    Rohde, David
    Voelkers, Mirko
    Filusch, Arthur
    Bruckner, Thomas
    Borst, Mathias M.
    Katus, Hugo A.
    Meyer, F. Joachim
    RESPIRATORY RESEARCH, 2009, 10
  • [4] Ambrisentan -: Treatment of pulmonary arterial hypertension endothelin ETA receptor antagonist
    Sorbera, LA
    Castañer, J
    DRUGS OF THE FUTURE, 2005, 30 (08) : 765 - 770
  • [5] Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension
    Steiner, M. Kathryn
    Preston, Ioana R.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (05) : 943 - 952
  • [6] Sitaxsentan: an endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension
    O'Callaghan, DS
    Gaine, SP
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (04) : 475 - 481
  • [7] Treatment of pulmonary arterial hypertension with macitentan, dual endothelin receptor antagonist
    Bichara, Valentina M.
    Bevacqua, Raul J.
    INSUFICIENCIA CARDIACA, 2019, 14 (03) : 119 - 128
  • [8] Treatment of pulmonary arterial hypertension with the dual endothelin receptor antagonist macitentan: clinical evidence and experience
    Belge, Catharina
    Delcroix, Marion
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2019, 13
  • [9] Ambrisentan, an endothelin receptor type A-selective endothelin receptor antagonist for the treatment of pulmonary arterial hypertension
    Kingman, Martha
    Ruggiero, Rosechelle
    Torres, Fernando
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (11) : 1847 - 1858
  • [10] Characteristics and risk factors of pulmonary arterial hypertension in patients with primary Sjogren's syndrome
    Yan, Shumin
    Li, Mengtao
    Wang, Hui
    Yang, Xiaoxi
    Zhao, Jiuliang
    Wang, Qian
    Liu, Yongtai
    Lai, Jinzhi
    Tian, Zhuang
    Song, Hui
    Zhao, Yan
    Zeng, Xiaofeng
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2018, 21 (05) : 1068 - 1075
12345